Differing pattern of ambulatory blood pressure in very elderly men expresses dynamics in atherosclerotic load in the

Arkadiusz Siennicki-Lantz1, Sölve Elmståhl

  • 1Division of Geriatric Medicine, Department of Health Sciences, Skane University Hospital in Malmö, Lund University, SE-205 02 Malmö, Sweden.

Insights

Vascular risk factors in 68-year-old men did not predict higher ambulatory blood pressure measurement (ABPM) at age 82. However, increasing clinic blood pressure and atherosclerosis correlated with higher ABPM later in life.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Vascular risk factors significantly influence cardiovascular health in aging populations.
  • Understanding long-term impacts on blood pressure is crucial for geriatric care.

Purpose of the Study:

  • To evaluate the influence of vascular risk factors on ambulatory blood pressure measurement (ABPM) in elderly men.
  • To determine predictors of ABPM at age 82 based on earlier risk factor status.

Main Methods:

  • A population-based cohort of men was followed from age 68 to 82.
  • Ambulatory blood pressure measurement (ABPM) was performed on 104 survivors at age 82.
  • Vascular risk factors including hypertension, clinic blood pressure (CBP), smoking, and ankle-brachial index (ABI) were assessed.

Main Results:

  • At age 68, hypertension and high CBP did not predict ABPM. Smoking and low ABI predicted higher ABPM variability and pulse pressure (PP).
  • At age 82, hypertension, high or increasing CBP, strongly correlated with all ABPM variables.
  • Carotid stenosis and declining ABI correlated with higher nocturnal ABPM and PP.

Conclusions:

  • Early vascular risk factors in men do not necessarily lead to elevated ABPM at age 82.
  • Higher ABPM in older age is associated with increasing clinic blood pressure and atherosclerosis progression over the preceding decade.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...